Wisconsin Board of Pharmacy Discussed Compounding Issues During October 31, 2012 meeting

Its agenda provided for discussion of the following:

K. Informational Item(s)
1) Discussion and Consideration of New England Compounding Center’s Contaminated Product
(39-40)
2) Discussion and Consideration as to Ther-Rx Letter (41-54)
3) Discussion and Consideration of USP Releases (55-56)

To view the entire agenda click here

Washington Board of Pharmacy Discussed Compounding during Its November Meeting

On its agenda was the following item:


5.1 Pharmacy Compounding Practice. The board will discuss the scope of pharmacy practice in
compounding pharmaceutical products and consider a response to the Ther-Rx Corporation letter
reviewed at the September meeting. Information/Action

To view entire agenda click here

Washington State Board of Pharmacy To Discuss Compounding Practice Tomorrow

1:50 p.m. DISCUSSION
5.1 Pharmacy Compounding Practice. The board will discuss the scope of pharmacy practice in compounding pharmaceutical products and consider a response to the Ther-Rx Corporation letter reviewed at the September meeting. Information/Action
Source found here

Washington State Board of Pharmacy: Ther-Rx Corp Letter

The Washington State Board of Pharmacy had on its September 27, 2012 agenda to discuss:

3.10 Correspondence. The board may discuss any correspondence received or distributed. Information/Action.
a) Ther-Rx Corp. letter re: Compounding of Hydroxyprogesterone Caproate

Once the minutes to the meeting are posted, I will update you on what position the Washington State Board of Pharmacy has taken.

Pennsylvania State Board of Pharmacy Meeting Today to Discuss Compounding Issue

Pennsylvania's Board of Pharmacy Agenda for today, September 18, 2012, indicates that the following will be discussed:

Ther-Rx Corporation – Compounding of hydroxyprogesterone caproate
injection ..

To view the entire agenda click here